Our vision

Lightning API was founded with the vision of bringing accurate, honest insights to accelerate patient access to new and beneficial health technologies


Our team has extensive experience across industry, government and strategic consultancy with a commitment to aligning commercial objectives with evidence and value demonstration for healthcare technologies.

Leadership team


Andrew Satherley

Joint Managing Director

“I am committed to supporting the development of healthcare innovation with rapid access to strategic insight”


James Whitehouse

Joint Managing Director

“I am driven by striking a fair balance between demand and supply in healthcare systems”


F. David Alcraft


"I am using my experience to establish, with my colleagues, an efficient platform for product pricing to ensure timely access for patients.”


Fiona Paton


"I see a real need to improve the efficiency of collection and analysis of market access data, from rapid early insights to in-depth studies"


Advisory team

Lightning API is working with leading industry and policy stakeholder across EU, US and other major markets


Dr Gary Owens

Executive Advisor (US)

Dr Owens is a US payer expert with over 30 years experience spanning medical and pharmacy management, technology evaluation, medical policy and consultancy

Jim Furniss.jpg

Jim Furniss

Executive Advisor (EU)

Jim Furniss was formerly head of the UK drugs budget and now advises companies on market access for pharmaceuticals in Europe, North America and the rest of the world.


Peter Carr

Executive Advisor (Industry)

Peter is an experienced senior consultant and former UK General Manager of Fujisawa (now Astellas) with a wealth of understanding across the spectrum of commercial activities.


Dr Rosemarie Delaney

Executive Advisor (Industry)

Dr Delaney is a market access consultant and former European Market Access Director at BMS, with over 20 years experience in a variety of industry roles covering pharmaceuticals, medical devices and vaccines.


Dr Frances Macdonald

Executive Advisor (European HTA)

Dr Macdonald was a member of the Scottish Medicines Consortium for 7 years, with extensive prior industry experience in product development, market access and commercial leadership.


Cheryl Ball

Executive Advisor (Global Market Access)

Cheryl is a market access specialist, with over 20 years of cross-functional experience in pricing/reimbursement, commercial strategy, market insights, and business development.